S C Tentoni|K A High - JoVE Visualize

Showing results (41-50 of 69) with videos related to

Pageof 7

Sort By:

Journal of Thrombosis and Haemostasis : JTH|June 29, 2004

Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparinH C Whinna, E B Lesesky, D M Monroe, et al.

Archives of Pathology & Laboratory Medicine|June 1, 1993

Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzerV L Rose, S C Dermott, B F Murray, et al.

Blood|October 1, 1989

Molecular characterization of human factor XSan AntonioS V Reddy, Z Q Zhou, K J Rao, et al.

Biochemistry|May 16, 1998

Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.

Human Gene Therapy|March 1, 1994

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexesJ N Lozier, A R Thompson, P C Hu, et al.

Blood|February 3, 1998

Human factor IX corrects the bleeding diathesis of mice with hemophilia BS H Kung, J N Hagstrom, D Cass, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusR W Herzog, J N Hagstrom, S H Kung, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9P A Fields, V R Arruda, E Armstrong, et al.

Blood|May 1, 1989

Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.

Gene Therapy|July 13, 2012

Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissueF Mingozzi, Y Chen, S C Edmonson, et al.

Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:

Pageof 7

Journal of Thrombosis and Haemostasis : JTH|June 29, 2004

Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparinH C Whinna, E B Lesesky, D M Monroe, et al.

Archives of Pathology & Laboratory Medicine|June 1, 1993

Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzerV L Rose, S C Dermott, B F Murray, et al.

Blood|October 1, 1989

Molecular characterization of human factor XSan AntonioS V Reddy, Z Q Zhou, K J Rao, et al.

Biochemistry|May 16, 1998

Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.

Human Gene Therapy|March 1, 1994

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexesJ N Lozier, A R Thompson, P C Hu, et al.

Blood|February 3, 1998

Human factor IX corrects the bleeding diathesis of mice with hemophilia BS H Kung, J N Hagstrom, D Cass, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusR W Herzog, J N Hagstrom, S H Kung, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9P A Fields, V R Arruda, E Armstrong, et al.

Blood|May 1, 1989

Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.

Gene Therapy|July 13, 2012

Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissueF Mingozzi, Y Chen, S C Edmonson, et al.

Pageof 7